News &amp; Updates

The use of baloxavir marboxil demonstrates good tolerability in children aged <1 year, with no new safety signals seen, according to a study.

Baloxavir use appears safe in flu-infected infants

Flu shots in pregnant mums lower infant infection rates

Maternal influenza vaccination during pregnancy appears to reduce the incidence of infection in infants, with the protective effect being more pronounced when vaccination is administered in the second or third trimester, according to a study.

Flu shots in pregnant mums lower infant infection rates

Advancing renal protection strategies in CKD: From evidence to action

At the 29^th Hong Kong Medical Forum, Professor Bobby Chacko of the University of Newcastle, Australia, discussed a topic of urgent global relevance: advancing renal protection strategies for a broader impact in chronic kidney disease (CKD). This editorial summarizes and expands upon the key points discussed — particularly the imperative to transition from knowledge to action in chronic kidney care.

Advancing renal protection strategies in CKD: From evidence to action

Closing LDL-C treatment gaps with nonstatin options: Insights from European registries

Cardiovascular disease (CVD) accounts for nearly half of all deaths in Europe. Despite the introduction of lower LDL-cholesterol (LDL-C) treatment targets, effective LDL-C control remains challenging. At the Advances in Medicine (AIM) 2025 meeting, Professor Andreas Schäfer from Hannover Medical School, Hannover, Germany, discussed unmet needs in LDL-C control across Europe and shared new clinical insights on bempedoic acid.

Closing LDL-C treatment gaps with nonstatin options: Insights from European registries

Pegcetacoplan delivers in rare CMKDs causing nephrotic-range proteinuria

In patients with either C3G or primary IC-MPGN presenting with nephrotic-range proteinuria, treatment with pegcetacoplan reduces proteinuria and C3c renal biopsy staining and stabilizes kidney function, according to results from a post hoc analysis of VALIANT presented at ERA 2025

Pegcetacoplan delivers in rare CMKDs causing nephrotic-range proteinuria

GLP-1RAs protective against dementia, stroke in people with T2D, obesity

28 Jul 2025 by

For adults with type 2 diabetes (T2D) and obesity, the use of glucagon-like peptide 1 receptor agonists (GLP-1RAs) semaglutide and tirzepatide provides substantial protection against dementia, stroke, and death, according to a large retrospective cohort study.

GLP-1RAs protective against dementia, stroke in people with T2D, obesity

SGLT-2 inhibitors show no risk increase in UTI among veterans

The use of SGLT-2 inhibitors does not appear to pose an elevated risk of urinary tract infection (UTI) among male veterans with type 2 diabetes (T2D), a recent study has shown.

SGLT-2 inhibitors show no risk increase in UTI among veterans

Maternal fish, nuts consumption a boon to kid's brain function

28 Jul 2025 by

Higher maternal consumption of nuts and large fatty fish during pregnancy appears to improve some aspects of neuropsychological function in children and adolescents, according to a study.

Maternal fish, nuts consumption a boon to kid's brain function

Is ATII safe for patients on mechanical circulatory support?

Patients on mechanical circulatory support (MCS) receiving angiotensin II (ATII) appear to be more susceptible to thrombosis, reveals a study, noting that the outcome is not statistically significant.

Is ATII safe for patients on mechanical circulatory support?

Daily emollient application in infants a feasible way to reduce AD burden

Daily emollient application in infants helps reduce the cumulative incidence of atopic dermatitis throughout the 2 years of life and may be a feasible way to reduce its burden in communities, according to a study.

Daily emollient application in infants a feasible way to reduce AD burden